301 related articles for article (PubMed ID: 34298128)
1. A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system.
Kondratov O; Kondratova L; Mandel RJ; Coleman K; Savage MA; Gray-Edwards HL; Ness TJ; Rodriguez-Lebron E; Bell RD; Rabinowitz J; Gamlin PD; Zolotukhin S
Mol Ther; 2021 Sep; 29(9):2806-2820. PubMed ID: 34298128
[TBL] [Abstract][Full Text] [Related]
2. Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-Labeled Adeno-Associated Virus Capsids Administered to Cerebral Spinal Fluid.
Rosenberg JB; Fung EK; Dyke JP; De BP; Lou H; Kelly JM; Reejhsinghani L; Ricart Arbona RJ; Sondhi D; Kaminsky SM; Cartier N; Hinderer C; Hordeaux J; Wilson JM; Ballon DJ; Crystal RG
Hum Gene Ther; 2023 Nov; 34(21-22):1095-1106. PubMed ID: 37624734
[TBL] [Abstract][Full Text] [Related]
3. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.
Castle MJ; Turunen HT; Vandenberghe LH; Wolfe JH
Methods Mol Biol; 2016; 1382():133-49. PubMed ID: 26611584
[TBL] [Abstract][Full Text] [Related]
4. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.
Gray SJ; Nagabhushan Kalburgi S; McCown TJ; Jude Samulski R
Gene Ther; 2013 Apr; 20(4):450-9. PubMed ID: 23303281
[TBL] [Abstract][Full Text] [Related]
5. A multiplexed barcode approach to simultaneously evaluate gene delivery by adeno-associated virus capsid variants in nonhuman primates.
Stone D; Meumann N; Kuhlmann AS; Peterson CW; Xie H; Roychoudhury P; Loprieno MA; Vu XK; Strongin DE; Kenkel EJ; Haick A; Stensland L; Obenza WM; Parrott J; Nelson V; Murnane RD; Huang ML; Aubert M; Kiem HP; Büning H; Jerome KR
Hepatol Commun; 2023 Feb; 7(2):e0009. PubMed ID: 37074875
[TBL] [Abstract][Full Text] [Related]
6. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
[TBL] [Abstract][Full Text] [Related]
7. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
[TBL] [Abstract][Full Text] [Related]
8. Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea.
Frederick A; Sullivan J; Liu L; Adamowicz M; Lukason M; Raymer J; Luo Z; Jin X; Rao KN; O'Riordan C
Hum Gene Ther; 2020 Jul; 31(13-14):756-774. PubMed ID: 32578442
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy.
Choudhury SR; Fitzpatrick Z; Harris AF; Maitland SA; Ferreira JS; Zhang Y; Ma S; Sharma RB; Gray-Edwards HL; Johnson JA; Johnson AK; Alonso LC; Punzo C; Wagner KR; Maguire CA; Kotin RM; Martin DR; Sena-Esteves M
Mol Ther; 2016 Aug; 24(7):1247-57. PubMed ID: 27117222
[TBL] [Abstract][Full Text] [Related]
10. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasion.
Kellish PC; Marsic D; Crosson SM; Choudhury S; Scalabrino ML; Strang CE; Hill J; McCullough KT; Peterson JJ; Fajardo D; Gupte S; Makal V; Kondratov O; Kondratova L; Iyer S; Witherspoon CD; Gamlin PD; Zolotukhin S; Boye SL; Boye SE
Mol Ther; 2023 Dec; 31(12):3441-3456. PubMed ID: 37814449
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of Adeno-Associated Virus Gene Therapy Following Cerebrospinal Fluid-Directed Administration.
Chen X; Lim DA; Lawlor MW; Dimmock D; Vite CH; Lester T; Tavakkoli F; Sadhu C; Prasad S; Gray SJ
Hum Gene Ther; 2023 Feb; 34(3-4):94-111. PubMed ID: 36606687
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput
Westhaus A; Cabanes-Creus M; Rybicki A; Baltazar G; Navarro RG; Zhu E; Drouyer M; Knight M; Albu RF; Ng BH; Kalajdzic P; Kwiatek M; Hsu K; Santilli G; Gold W; Kramer B; Gonzalez-Cordero A; Thrasher AJ; Alexander IE; Lisowski L
Hum Gene Ther; 2020 May; 31(9-10):575-589. PubMed ID: 32000541
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals.
Hinderer C; Bell P; Katz N; Vite CH; Louboutin JP; Bote E; Yu H; Zhu Y; Casal ML; Bagel J; O'Donnell P; Wang P; Haskins ME; Goode T; Wilson JM
Hum Gene Ther; 2018 Jan; 29(1):15-24. PubMed ID: 28806897
[TBL] [Abstract][Full Text] [Related]
15. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing.
de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA
Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384
[TBL] [Abstract][Full Text] [Related]
16. Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.
Choudhury SR; Harris AF; Cabral DJ; Keeler AM; Sapp E; Ferreira JS; Gray-Edwards HL; Johnson JA; Johnson AK; Su Q; Stoica L; DiFiglia M; Aronin N; Martin DR; Gao G; Sena-Esteves M
Mol Ther; 2016 Apr; 24(4):726-35. PubMed ID: 26708003
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of novel engineered AAV capsids facilitates enhanced transgene expression in the macaque CNS.
Stanton AC; Lagerborg KA; Tellez L; Krunnfusz A; King EM; Ye S; Solomon IH; Tabebordbar M; Sabeti PC
Med; 2023 Jan; 4(1):31-50.e8. PubMed ID: 36417917
[TBL] [Abstract][Full Text] [Related]
18. scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution.
Öztürk BE; Johnson ME; Kleyman M; Turunç S; He J; Jabalameli S; Xi Z; Visel M; Dufour VL; Iwabe S; Pompeo Marinho LFL; Aguirre GD; Sahel JA; Schaffer DV; Pfenning AR; Flannery JG; Beltran WA; Stauffer WR; Byrne LC
Elife; 2021 Oct; 10():. PubMed ID: 34664552
[TBL] [Abstract][Full Text] [Related]
19. Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants.
Rapti K; Maiakovska O; Becker J; Szumska J; Zayas M; Bubeck F; Liu J; Gerstmann E; Krämer C; Wiedtke E; Grimm D
J Vis Exp; 2022 Oct; (188):. PubMed ID: 36342179
[TBL] [Abstract][Full Text] [Related]
20. Intravenous Infusion of AAV for Widespread Gene Delivery to the Nervous System.
Gessler DJ; Tai PWL; Li J; Gao G
Methods Mol Biol; 2019; 1950():143-163. PubMed ID: 30783972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
